Pediatric Maxillary Giant Cell Tumors: Surgical Management by Transoral and Endoscopic Transnasal Enucleation and Curettage

J Craniofac Surg. 2022 Oct 1;33(7):e747-e750. doi: 10.1097/SCS.0000000000008689. Epub 2022 Aug 1.

Abstract

Giant cell tumors are uncommonly found within the craniofacial skeleton, and of those within the head and neck, are exceedingly rare in the maxilla. Here the authors present 2 cases of large, maxillary giant cell tumors: one presenting with mass-effect symptoms and another presenting from incidental findings on routine orthodontic care. Both patients were treated surgically with transoral and endoscopic transnasal excision and demonstrated favorable surgical results. One patient demonstrated no recurrence after 9 years and the other patient was disease free after 4 years. The authors end by discussing the role of emerging biologic agents, such as denosumab, for treating giant cell tumors of the jaws.

MeSH terms

  • Biological Factors
  • Bone Density Conservation Agents*
  • Bone Neoplasms* / surgery
  • Child
  • Curettage / methods
  • Denosumab
  • Giant Cell Tumor of Bone* / pathology
  • Humans
  • Maxilla / pathology
  • Retrospective Studies

Substances

  • Biological Factors
  • Bone Density Conservation Agents
  • Denosumab